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Abstract
A liquid chromatographic method of tetracycline and its major degradation products on a C8-reversed phase
column with acidic mobile phase and fluorescence detection is described. The quantification limit, measured as the
amount of sample that gave a signal ten times the peak-to-peak noise of the baseline, was: 0.25 ng for tetracycline
(TC) and epitetracycline (ETC), 25 ng for and 4-epianhydrotetracycline (EATC) and 50 ng for anhydrotetracycline
(ATC) of injected standard. By means of this liquid chromatography (LC) assay TC, ETC, EATC and ATC as main
degradation products of tetracycline, can be separated and determined with good sensitivity and specificity within 15
min. © 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Tetracycline antibiotic is widely prescribed in
animal husbandry. It is used for the prevention
and control of disease and as feed additives to
promote weight gain and increase feed conversion
efficiency.
Veterinary pharmaceutical formulations of te-
tracycline (TC) contain small amounts of impuri-
ties namely 4-epitetracycline (ETC), anhydro-
tetracycline (ATC) and 4-epianhydrotetracycline
(EATC). Tetracycline used in feed additives are
even less pure. The source of the tetracycline used
in feeds is the residual tetracycline found in the
dried, ground mycelial powder harvested from
fermentation tanks [1].
These compounds may also have origin if
stored under adverse conditions, e.g. high temper-
ature and humidity [2]. It must be realized that
degradation products of tetracyclines can also
occur in the stomach [3].
It is important to determine not only the tetra-
cycline and its major degradation products in* Corresponding author. Fax: 351-39-27126.
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pharmaceutical formulations but also in biologi-
cal and food samples. Next to a decrease of
potency, degradation can lead to toxic degrada-
tion products. This is already proven for EATC
and ATC [4,5].
Permitted concentrations of these impurities in
pharmaceutical formulations are fixed by the Eu-
ropean Pharmacopoeia [6].
Since the residues in biological and food sam-
ples, are products of metabolism they consist of
the parent drug and all compounds derived from
it, such as free metabolites. The maximum residue
levels (LMR) in foods for TC, established by the
European Community (EC) [7] are for the parent
compound and its epimer. Therefore, it is also
very important to develop methods for its deter-
mination in food samples.
The stability of TC is poor under strong acidic
and alkaline conditions with reversible formation
of epimers at position C4 to 4-epitetracycline
(ETC) in weak acid (pH 3) and to anhydro-TC
under strong acidic (below pH 2) conditions [8].
Epimerization on carbon-4 in tetracycline,
which is a reversible first-order process, occurs
most rapidly between pH 3 and 5. The presence of
a hydroxyl group at C6 favors dehydration and
aromatization of the C-ring of tetracycline follow
pseudo-first-order kinetics, leading to ATC at
very low pH. The epimerization of ATC, and the
dehydration of the ETC lead to the formation of
EATC [9] (Fig. 1).
The toxic effects of ATC were attributed to the
relative position of the dimethylamino group (on
C4) [10].
Several papers dealing with the liquid chro-
matographic determination of tetracyclines and
their degradation products have been published
[11,12]. Those reports deal mainly with the deter-
mination of tetracyclines in pharmaceutical prepa-
rations, where relatively high concentrations are
involved, but it is also important determine their
presence in biological and food samples at resid-
ual levels. Therefore, it was essential to introduce
a more sensitive detection method.
Fluorescence detection of tetracyclines is more
specific and also in many cases more sensitive
than UV detection normally used [13], and its a
important tool in the analysis of tetracycline
residues in biological and food samples.
In this paper a LC method with fluorescence
detection, according to the Haagsma method [14]
validated in our laboratory for the residue analy-
sis of oxytetracycline (OTC), tetracycline (TC)
and chlortetracycline (CTC), was tested for the
Fig. 1. Structures of tetracycline and its major related substances.
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analysis of TC, ETC, EATC and ATC. The pre-
sented method utilizes the fluorescence produced
when tetracyclines reacted with magnesium ions.
Most tetracyclines fluorescence in the presence
of magnesium ions, and this fluorescence is in-
tensified by the addition of a base such as
sodium hydroxide [15].
Tetracycline was found to fluorescence more if
heated to produce anhydro-salts before complex-
ation [16]. During dehydration, two double
bonds are added to the tetracycline nucleus,
producing stable anhydro forms and increasing
fluorescence. Therefore, this property can be
used for a more sensitive detection of the anhy-
dro forms, measured as anhydro-TC–magne-
sium complexes.
The objective was develop an LC system
which gives fast separation and determination
with good sensitivity and selectivity, of TC,
ETC, EATC and ATC as main metabolites of
tetracycline, suitable for their precise routine
analysis in biological and food samples.
2. Experimental
2.1. Instrumentation
A Gilson model 302, 305 and 307 pumps, a
model 7125 loop injector (Rheodyne, Cotati,
CA) and a Perkin Elmer LS-3B fluorescence de-
tector operated at an excitation wavelength of
385 nm and an emission wavelength of 500 nm
were used. The spectral band width was 10 nm
for both excitation and emission. Mobile phase
flow 0.8 ml min1. The derivatization reagent
was delivered at a flow rate of 0.45 ml min1.
The results were recorded on a 3390A chro-
mato- integrator Hewlett Packard. The LC
column used was a Chromspher C8, 100-3 mm
(Chrompack, Bergen op Zoom, The Nether-
lands).
2.2. Reagents
Caution: tetracyclines are irritants and tetracy-
cline itself is a possible teratogen. Handle tetra-
cyclines standards with care. Prepare mobile
phases in well-ventilated chemical fume hood.
Avoid contact with skin.
1. Water was purified by distillation and passage
through Milli-Q system (Millipore). The water
was filtered through a 0.45 mm filter under
vacuum and degassed by ultrasonication.
2. All the solvents were LC grade and were pur-
chased from Carlo Erba (Italy). Oxalic acid,
magnesium acetate, boric acid, potassium hy-
droxide and sodium hydroxide were analytical
reagent grade chemical obtained from Merck
(Germany).
3. Tetracycline (TC) was obtained from Sigma
Chemical (Spain). ETC, EATC and ATC were
purchased from European Pharmacopoeia. In-
dividual stock standard solutions of TC, ETC,
EATC and ATC were prepared in 100 ml
methanol containing 100 mg neat standard
into a volumetric flask, and was stored at
20°C in brown glass vials for a maximum
period of one month. Tetracycline was cor-
rected to 100% purity.
The working solutions were a mixture of the
four compounds prepared by a serial dilution of
the stocks and were stored in brown glass vials at
4°C. These solutions were prepared immediately
before use.
The mobile phases used for analysis containing
aqueous oxalic acid solution (pH 2.0; 0.01 M) and
20–40% of acetonitrile. The mobile phases were
filtered through a 0.45 mm filter under vacuum,
degassed by ultrasonication.
The reagent post-column was prepared daily,
dissolving 6.0 g of magnesium acetate, 6.1 g boric
acid and 2.5 g of potassium hydroxide in 950 ml
of water, adjusted with 1 M sodium hydroxide
and make up to 1 l. Its important to follow the
order of addition of these reagents, because pre-
cipitations may occur. This solution was filtered
through a 0.45 mm filter under vacuum and de-
gassed by ultrasonication, was held in a brown
glass bottle.
All glassware was cleaned with Extran MA 03,
Merck, Germany; 10% v:v, rinsed in concentrated
acid-dichromate solution, washed thoroughly with
tap water, rinsed with deionized water and dried
at 80°C.
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Table 1
Linear regression of the assay response for TC, ETC, EATC and ATC
Slope SE Intercept Intercept SE Coefficient of correlationCompound Slope
0.9990.0713710.02880.009429ETC 0.6697
0.0417 0.325520TC 1.02939 0.9980.043006
0.9960.2637430.01620.003484EATC 0.0746
0.0993 0.139281ATC 0.1306 0.9930.001840
3. Results
The standard curves were tested for linearity in
the range of 2.5–25 ng for ETC and TC, and
50–250 ng for EATC and ATC, of injected
amount.
The linear regressions of the assay response for
TC, ETC, EATC and ATC are shown in Table 1.
The correlation coefficients for the regression
equation for TC, ETC, EATC and ATC were
greater than 0.993, showing the standard curve to
be linear within the range of standards used.
The quantification limits, measured as that
amount of sample that gave a signal ten times the
peak-to-peak noise of the baseline, were: 0.25 ng
for TC and ETC, 25 ng for EATC and 50 ng for
ATC of injected standard.
The quantification of small amounts of impuri-
ties can be realized owing to the good separation
and sensitivity.
Within-day precision were determined by
analysing five standard solutions at two levels of
concentration (ETC and TC at 25 and 2.5 ng and
EATC and ATC at 250 and 50 ng), whilst be-
tween-day precision were determined by analysing
the same standard solutions on 5 successive days.
We obtained coefficients of variation between 2.4
and 3.5% and 9.0 and 4.1% respectively, showing
a good precision of the method.
The individual stock standard solutions of TC,
ETC, EATC and ATC were prepared in methanol
and stored at 20°C in brown glass vials. We did
not observe significant alterations over a maxi-
mum period of 1 month. The working solutions
were a mixture of the four compounds prepared
by a serial dilutions of the stocks with methanol,
in brown glass vials, and were prepared daily,
immediately before use. Some care was taken with
these solutions: they were always kept at 4°C and
protected from light, immediately after the injec-
tion in the chromatographic system, they were not
allowed to stand in the laboratory at room tem-
perature. Under these conditions no appreciable
decomposition was observed in these solutions for
approximately 1 working day (8–12 h).
The good repeatability mentioned in the cali-
bration is an indication for the good stability of
this compounds during the chromatographic
analysis.
4. Discussion
The quantification limits achieved by the
present method are in agreement with the MRL
established by the European Comminity for TC
and its epimer in foods and in the same chromato-
graphic run we can also averiguate the presence of
the toxic EATC and ATC. Since the anhydro-
TC–magnesium complexes are highly fluorescent
the method is more sensitive for these compounds
permitting the separation of very small amounts
of EATC and ATC and small amounts of ETC
can be separated from TC, according to the Eu-
ropean Pharmacopoeia permitted concentrations
for pharmaceutical preparations.
Chromatography of anhydrotetracyclines is
some what more difficult to achieve than that the
parent compounds because of the lower polarity
of the former.
A study on reversed-phase LC of TC and its
degradation products using acid mobile phases
was first published by Knox et al. [17].
The method presented utilizes a C8 Chromo-
spher column at room temperature with acetoni-
trile–0.01 M oxalate buffer (pH 2) as the mobile
A. Pena et al. : J. Pharm. Biomed. Anal. 18 (1998) 839–845 843
phase. Tetracyclines form chelate complexes with
ions at b-diketones (C10–C12) and carboxyamide
(C2) [18] and bind with silanol groups in the
stationary phase [19]. In an acidic medium (pH
1–2.5) the tetracycline molecule is fully proto-
nated and exists in its cationic form [20,21] and
can be paired with a suitable anion such as ox-
alate [22]. On the other hand, all tetracyclines had
the best asymmetric values at pH 2 [23].
Following elution, tetracyclines are derivatized
with Mg2 ions at room temperature to produce
a highly fluorescent derivative. The fluorescence
detector is set with an excitation wavelength of
385 nm and an emission wavelength of 500 nm.
The development of the fluorimetric method
was based upon experience obtained with the
analysis of OTC, TC and CTC. The fluorescence
response is dependent upon pH. For a maximum
fluorescence a pH greater than 8 is essential, and
is associated with the ionized form of the pheno-
lic-b-diketone site of these molecules. The pH is
adjusted with the addition of the post-column
reagent, prepared in alkaline solution at pH 9.
The fluorescence response is also dependent
upon the flow rate of derivatization reagent. In
our study the fluorescence response reached a
maximum at 0.45 ml min1. Post-column deriva-
tization does not directly affect the chromato-
graphic properties of the tetracyclines, however
the reaction chemistry must be rapid on the chro-
matographic time scale in order to preserve the
chromatographic information.
Post-column derivatization has also the advan-
tage that a separate sample treatment step is not
required and the analytes are better separated
from interferences prior to derivatization.
Preliminar work was carried out on isocratic
analysis, making several variations of the ratio of
organic modifier and aqueous oxalic acid in the
mobile phase.
The composition of acid mobile phases must be
established very well, because complete separation
of TC and ETC is obtained only with mobile
phases which are too weak to eluted the more
strongly retained EATC and ATC within a rea-
sonable time. The retention decrease directly with
concentration of acetonitrile in the mobile phase.
We can obtain shorter retention times of EATC
and ATC altering the concentration of organic
modifier.
We have tried several modifications of the per-
centage of acetonitrile in the mobile phase, so
those anhydrotetracyclines eluted after the tetra-
cycline with good resolution, permitting also the
separation of tetracycline and his epimer.
The isocratic analysis using acetonitrile–oxalic
acid solution (pH 2.0; 0.01 M) (30:70, v:v) as
mobile phase, allows the separation of the four
compounds but with bad resolution.
With 20% of acetonitrile the resolution between
ETC and TC was good but EATC and ATC
eluted very late with bad resolution.
An increase of the acetonitrile concentration to
40% finally enable the elution of EATC and ATC
but with this mobile phase ETC overlapped with
the TC peak.
Several variations of the ratio of acetonitrile in
the acid mobile phases did not yield substantially
better separations, and some improvement was
achieved by the use of gradient elution as we can
observe in Fig. 2, showing greater resolution of
these compounds. The gradient was chosen based
in this work experience, to allow for optimum
separation. We have applied the follow gradient:
from 0 to 5 min 20% of acetonitrile and 80% of
oxalic acid (pH 2.0; 0.01 M), from 5 to 16 min
40% of acetonitrile and 60% of oxalic acid (pH
2.0; 0.01 M) and at 17 min 30% of acetonitrile
and 70% of oxalic acid (pH 2.0; 0.01 M), at a
constant flow of 0.8 ml min1.
5. Conclusions
Methanol was chosen as the universal solvent
for the tetracyclines, because of its ability to
dissolve the tetracyclines and its miscibility with
aqueous and organic solvents. Methanol was also
chosen because aqueous solvents tend to acceler-
ate degradation of tetracyclines compounds.
Because many reversed-phase materials are un-
stable at pH lower than 2–3 it was necessary to
flush the columns with a neutral solvent (e.g.
water–acetonitrile 50:50) for 1 h at the end of
each working day [22]. This practice contributed
markedly to the prolonging of the column life.
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Although the C18-bound materials are more
suitable for analysing the impurities of TC, show-
ing better resolution (Rs) values, we obtained
good symmetrical peaks using a Chromspher C8
column. Our results show that even though a C8
column was used, we obtained good performance.
This method enables good separations of TC,
ETC, EATC and ATC.
The methodology reported herein use a simple
solvent system containing a low concentration of
buffer, avoiding the drawbacks related with its use
for the chromatographic system. Its also allows
analysis of the tetracyclines and its degradation
products with the same chromatographic column.
Although the analysis was performed at pH 2,
this system was proven not to cause any epimer-
ization of TC. Formation of EATC and ATC due
to partial degradation of ETC and TC in the
strong acidic mobile phase also was not observed.
The epimer of TC is always eluted first, while
its anhydro-forms are most retained in agreement
with the polarity of the tetracycline compounds.
Accordingly to polarity of the chromatographic
column anhydro-forms, EATC and ATC, are
eluted with good resolution only with a high
percentage of acetonitrile in the mobile phase.
With this LC method we can differentiate be-
tween the tetracycline and their major degrada-
tion products, at residue level within 15 min. Thus
it is possible to ascertain whether the tetracyclines
determined in biological and food samples are the
intact molecule originally applied or some fluores-
cent degradation and food products. The high
degree of selectivity achieved in using a post-
column reaction and fluorescence detection, that
is less prone to interference from other com-
pounds in the sample matrix, has considerable
potential as a basis for the development of a
method for the determination of these compounds
in biological and food samples, since we will can
minimize the complex time consuming sample
extraction and clean-up procedures.
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